Name | 4,5-Dibromo-o-xylene |
Synonyms | 4,5-Dibromo-o-xylene 4,5-DIBROMO-O-XYLENE 2-Dibromo-4,5-dimethylbenzene 1,2-Dibromo-4,5-dimethylbenzene 1,2-DiMethyl-4,5-dibroMobenzene 1,2-DIBROMO-4,5-DIMETHYLBENZENE 4,5-DIBROMO-1,2-DIMETHYLBENZENE Benzene, 1,2-dibromo-4,5-dimethyl- |
CAS | 24932-48-7 |
InChI | InChI=1/C8H8Br2/c1-5-3-7(9)8(10)4-6(5)2/h3-4H,1-2H3 |
InChIKey | BCIDDURGCAHERU-UHFFFAOYSA-N |
Molecular Formula | C8H8Br2 |
Molar Mass | 263.96 |
Density | 1.7485 (rough estimate) |
Melting Point | 85-89 °C (lit.) |
Boling Point | 278 °C |
Flash Point | 138.7°C |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
Vapor Presure | 0.00694mmHg at 25°C |
Appearance | Solid |
Color | White to Pale Yellow |
BRN | 2206183 |
Storage Condition | Inert atmosphere,Room Temperature |
Refractive Index | 1.6146 (estimate) |
MDL | MFCD00082743 |
Hazard Symbols | Xi - Irritant![]() |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37 - Wear suitable protective clothing and gloves. |
WGK Germany | 3 |
HS Code | 29039990 |
Hazard Class | IRRITANT |
Use | 1,2-dibromo-4, 5-dimethylbenzene is used as a synthetic reagent (T338850) for thalidomide; FGF-induced angiogenesis and replication inhibitor of type 1 human immunodeficiency virus. It is also a teratogenic sedative and immunomodulator, mainly in combination with dexamethasone, used to treat multiple myeloma. |